CAS 23672-07-3
:Lévosulpiride
- (-)-5-Aminosulfonyl-N-[(1-Ethyl-2-Pyrrolidinyl)Methyl]-2-Methoxy-Benzamide
- (-)-N-1-[Ethylpyrrolidin-2-Ylmethyl]-2-Methoxy-5-Sulfamoylbenzamide
- (-)-Sulpiride
- (S)-(-)-5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolinyl)methyl]
- (S)-(-)-5-Aminosulfonyl-N-[(1-Ethyl-2-Pyrrolidinyl)Methyl]-2-Methoxybenzamide
- (S)-(-)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide
- (S)-(-)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide 5-(Aminosulfonyl)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-2-Methoxy-Benzamid ( S-(-)-Benzamid
- (S)-(-)-Sulpiride
- (S)-(-)-Sulpiride, Vetranal
- 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxybenzamide
- <span class="text-smallcaps">L</span>-Sulpiride
- Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (S)-
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-
- Lesuride
- Levobren
- Levopraid
- Levopride
- Levosulpride
- N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
- Rv-12309
- Rv-12309 S-(-)-N-(1-Ethyl-2-Pyrrolidinomethyl)-2-Methoxy-5-Sulfamoylebenzamide
- S(-)-Sulpiride Dopamine D1 Antagonis
- S-(-)-N-(1-Ethyl-2-Pyrrolidinomethyl)-2-Methoxy-5-Sulfamoylebenzamide
- Sulpid
- l-Sulpiride
- o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-, (-)-
- s-(-)-sulpiride (S)-5-Aminosulfonyl-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide
- LEVOSULPIRIDE/LEVOSULPRIDE
- (s)-(-)-o-anisamid
- LEVOSULPIRIDE
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-(9CI)
- Voir plus de synonymes
(S)-(-)-Sulpiride
CAS :Formule :C15H23N3O4SDegré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :341.43N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
CAS :Formule :C15H23N3O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :341.4258Levosulpiride
CAS :Levosulpiride (S-(-)-Sulpiride) is the (S)-enantiomer of sulpiride, which is a D2 receptor antagonist, an atypical antipsychotic drug of the benzamide class.Formule :C15H23N3O4SDegré de pureté :98.20% - 99.88%Couleur et forme :White Crystalline PowderMasse moléculaire :341.43Levosulpiride
CAS :Formule :C15H23N3O4SDegré de pureté :98.0 - 102.0 %Couleur et forme :White to off-white powderMasse moléculaire :341.43Levosulpiride
CAS :Formule :C15H23N3O4SCouleur et forme :White To Off-White SolidMasse moléculaire :341.43Levosulpiride
CAS :Produit contrôléFormule :C15H23N3O4SCouleur et forme :NeatMasse moléculaire :341.43S-(-)-Sulpiride
CAS :Produit contrôléApplications Dopamine D2 and D3-receptor antagonist. Antipsychotic; antidepressant; antiemetic.
References Pitre, D., et al.: Anal. Profiles Drug Subs., 17, 607 (1988), Wagstaff, A.J., et al.: CNS Drugs, 2, 313 (1994),Formule :C15H23N3O4SCouleur et forme :WhiteMasse moléculaire :341.43Levopride
CAS :Applications Antipsychotic; antidepressant; antiemetic.
References Karolidis, D., et al.: Med. Chem., 6, 259 (2010), Cummings, D., et al.: J. Pharmacol. Exper. Ther., 335, 518 (2010),Formule :C15H23N3O4SCouleur et forme :WhiteMasse moléculaire :341.43Levosulpiride
CAS :Produit contrôléLevosulpiride is a pharmacological agent which binds to dopamine (D2) receptors in the brain and gastrointestinal tract. It is used both to treat conditions that cause abnormal movements for e.g. Parkinson's disease and tardive dyskinesia, and also as an antiemetic and to treat certain gastric disorders. Additional to acting as a dopamine receptor antagonist, Levosulpiride also binds to α1-acid glycoprotein and has been shown to have a concentration-dependent effect on serum prolactin levels, with higher doses leading to increased levels, as well as an effect on basic fibroblasts.Formule :C15H23N3O4SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :341.43 g/molLevosulpiride - Bio-X ™
CAS :Produit contrôléLevosulpiride is a pharmacological agent which binds to dopamine (D2) receptors in the brain and gastrointestinal tract. It is used both to treat conditions that cause abnormal movements for e.g. Parkinson's disease and tardive dyskinesia, and also as an antiemetic and to treat certain gastric disorders. Additional to acting as a dopamine receptor antagonist, Levosulpiride also binds to α1-acid glycoprotein and has been shown to have a concentration-dependent effect on serum prolactin levels, with higher doses leading to increased levels, as well as an effect on basic fibroblasts.
Formule :C15H23N3O4SDegré de pureté :(%) Min. 95%Couleur et forme :PowderMasse moléculaire :341.43 g/mol











